Attana AB (publ) (NGM:ATANA)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0070
0.00 (0.00%)
At close: Apr 27, 2026
-66.67%
Market Cap 18.06M
Revenue (ttm) 4.01M
Net Income (ttm) -11.03M
Shares Out 2.58B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,659,365
Average Volume 19,814,409
Open n/a
Previous Close 0.0070
Day's Range n/a
52-Week Range 0.0060 - 0.0330
Beta 0.88
RSI 44.77
Earnings Date Apr 30, 2026

About Attana AB

Attana AB (publ) provides analytical instruments and services for validating, selecting, and optimizing drug candidates primarily in Sweden. The company offers contract research services; in vitro diagnostic tools; analytical instruments; and Attana virus analytics. It serves pharmaceutical and biotechnology companies, and academic institutions. Attana AB (publ) was founded in 2002 and is headquartered in Sollentuna, Sweden. [Read more]

Industry Commercial Physical and Biological Research
Founded 2002
Employees 6
Stock Exchange Nordic Growth Market
Ticker Symbol ATANA
Full Company Profile

Financial Performance

In 2025, Attana AB's revenue was 4.01 million, a decrease of -39.40% compared to the previous year's 6.61 million. Losses were -11.03 million, -13.65% less than in 2024.

Financial Statements

News

There is no news available yet.